Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigator's Initiated Phase II Study for Pancreatic Cancer Patients

NCT01659502 is registered in ClinicalTrials.gov with Tiltan Pharma Ltd. as lead sponsor.

NCT NCT01659502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01659502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigator's Initiated Phase II Study for Pancreatic Cancer Patients
Lead sponsor
Tiltan Pharma Ltd.
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2013
Completion date
Not reported
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer